It is January 1 of year 0, and Lilly is considering developing a new drug called Dialis. We are given the following information

■ On March 15 of year 0, Lilly incurs a fixed cost that is assumed to follow a triangular distribution with best case $10 million, most likely case $35 million, and worst case $50 million. This cost will be depreciated on a straight-line basis during years 1 to 6.

■ The product will be sold during years 1 to